Energy's high costs and thin margins keep its financials under pressure. Click to read more on why URG remains a Hold.

Pfizer ends phase 2 trial of maplirpacept for large B-cell lymphoma due to recruitment issues, not safety concerns. Read more here.

Mitsubishi Motors reports strong H1 2025 sales, up 5.1% YOY, with the redesigned Outlander leading. Eclipse Cross sales soar 80%.

“We believe a recovery is underway,” said Argus analyst John Staszak, and with the company clearing out outdated inventory and utilizing its e-commerce channel to improve pricing, the stock earned an ...

Interactive Brokers Group (IBKR) announced on Tuesday June daily average revenue trades of 3.448M, 40% higher year-over-year and 2% higher than prior month.

Butterfly Network's recent equity raise extends its cash runway, but 20% annual sales growth is insufficient for near-term ...

Aeva Technologies develops and manufactures lidar for various markets, including autonomous vehicles. Learn more about AEVA ...

Marks and Spencer's strong share growth is hindered by long-term brand risks, operational flaws, and low dividends.

Solar stocks jump after the US Senate passed the latest version of President Trump's tax and spending bill. Republicans ...

Focused on AI-driven growth with a covered call strategy and a 6% NAV discount, BST offers high-yield tech exposure. Click to ...

The NYLI MacKay California Muni Fund underperformed its benchmark, the Bloomberg Municipal Bond Index California Exempt, ...

New Gold's 123% EPS growth forecast, strong financial health, and bullish gold market exposure make it a top investment ...